Briakinumab (Anti-IL-12) (IL-12a & IL-12b)
Product Specifications
CAS Number
339308-60-0
SKU
C00684-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Briakinumab (anti-IL-12) (IL-12a & IL-12b) is a human monoclonal antibody directed against the human interleukins 12 (IL-12) and 23 (IL-23), with immunomodulating activity. It has the potential to be used in the treatment of Crohn's disease. MW: 143.86 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940009-100 1x 100 µL
MART-1 / Melan-A (M2-7C10), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400242-500 1x 500 µL
PTH / Parathyroid Hormone (N-Terminal) (3H9), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880260-100 1x 100 µL
IgM Immunoglobulin (IM260), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470918-100 1x 100 µL
CD44 Standard (HCAM/918), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882034-100 1x 100 µL
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (LPFS2/2034R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details